Omega Fund Management

Omega Fund Management as of Sept. 30, 2022

Portfolio Holdings for Omega Fund Management

Omega Fund Management holds 19 positions in its portfolio as reported in the September 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Replimune Group Common Stock (REPL) 27.1 $74M 4.3M 17.27
Imago Biosciences Common Stock 16.6 $45M 3.0M 15.05
Nuvation Bio Common Stock Class A (NUVB) 12.4 $34M 15M 2.24
Cincor Pharma Common Stock 6.7 $18M 561k 32.82
Gossamer Bio Common Stock (GOSS) 6.6 $18M 1.5M 11.98
Morphic Holding Common Stock (MORF) 6.2 $17M 598k 28.30
Alpine Immune Sciences Common Stock 5.4 $15M 2.0M 7.20
Kronos Bio Common Stock (KRON) 4.7 $13M 3.8M 3.35
Ikena Oncology Common Stock (IKNA) 2.9 $8.0M 2.2M 3.55
Immunic Common Stock (IMUX) 2.1 $5.7M 1.8M 3.16
Paratek Pharmaceuticals Common Stock 1.9 $5.1M 2.0M 2.57
Sana Biotechnology Common Stock (SANA) 1.9 $5.1M 844k 6.00
Omega Alpha SPAC Common Stock Class A 1.8 $5.0M 501k 9.93
Theseus Pharmaceuticals Common Stock 1.5 $4.1M 712k 5.80
Spruce Biosciences Common Stock (SPRB) 1.1 $3.0M 2.2M 1.37
Syros Pharmaceuticals Common Stock (SYRS) 0.6 $1.6M 251k 6.44
Jounce Therapeutics Common Stock 0.2 $645k 276k 2.34
ESSA Pharma Common Stock (EPIX) 0.2 $597k 328k 1.82
Senti Biosciences Common Stock (SNTI) 0.2 $425k 196k 2.17